PMLiVEBioMarin ups the ante for pivotal haemophilia gene therapy trialPMLiVEBioMarin is dramatically expanding the size of a phase III trial of its gene therapy for haemophilia A, after reporting long-term efficacy data from another study which showed … Continue reading
WRAL Tech WireNovartis-owned AveXis bringing $55M gene therapy factory, 200 jobs to DurhamWRAL Tech WireAveXis intends to use its new Durham facility to manufacture its first product candidate, AVXS-101, its proprietary gene therapy to treat three type… Continue reading
Gene therapies that could transform diseases get easier FDA pathSanta Fe New MexicanUnlike traditional drugs, gene therapies are intended to be given once, transform the inner workings of the body and last for a lifetime. For regulators, the challenge … Continue reading
Gene therapies that could transform diseases get easier FDA pathSanta Fe New MexicanUnlike traditional drugs, gene therapies are intended to be given once, transform the inner workings of the body and last for a lifetime. For regulators, the challenge … Continue reading
Gene therapies that could transform diseases get easier FDA pathSanta Fe New MexicanUnlike traditional drugs, gene therapies are intended to be given once, transform the inner workings of the body and last for a lifetime. For regulators, the challenge … Continue reading
KING5.com |
Doctors caution ‘buyers beware’ of stem cell treatments
KING5.com You name the pain – and a stem cell clinic seems raring to fix it, from knee pain to glaucoma. But some of these clinics may be too good to be true – and could even be dangerous. On a day off from filling cavities, Dr. Robert Radin was drilling golf … |
Science Daily |
Flow of cerebrospinal fluid regulates neural stem cell division
Science Daily Stem cells in the brain can divide and mature into neurons participating in various brain functions, including memory. In a paper published in the journal ‘Cell Stem Cell‘, scientists at Helmholtz Zentrum München and Ludwig-Maximilians-Universität … |
|
TEDCO grant to help fund stem cell research at Johns Hopkins Medicine
Maryland Daily Record The Maryland Technology Development Corp. (TEDCO) awarded a $750,000 grant to Miami-based biopharmaceutical company Longeveron LLC for stem cell research at Johns Hopkins University School of Medicine. The grant will go toward Longeveron’s … |